Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue    
Product revenue, net $ 34,921 $ 23,376
Revenue - from a related party 1,708 3,506
Net revenue 36,629 26,882
Operating expenses    
Cost of goods sold - product revenue 10,532 6,125
Research and development 75,236 83,333
Research and development - licenses acquired 6,090 4,050
General and administrative 55,590 53,371
Total operating expenses 147,448 146,879
Loss from operations (110,819) (119,997)
Other income (expenses)    
Interest income 2,559 1,104
Interest expense and financing fee (11,849) (10,340)
Change in fair value of derivative liability (27) (682)
Change in fair value of subsidiary convertible note 0 437
Change in fair value of investments 0 (1,390)
Gain on deconsolidation of Caelum 18,476 0
Other income 0 68
Total other income (expenses) 9,159 (10,803)
Loss from continuing operations (101,660) (130,800)
Discontinued operations:    
Gain from disposal of National 0 2,333
Loss from discontinued operations, net of tax 0 (13,469)
Total loss from discontinued operations 0 (11,136)
Net loss (101,660) (141,936)
Less: net loss attributable to non-controlling interests 61,700 57,789
Net loss attributable to common stockholders $ (39,960) $ (84,147)
Loss from continuing operations per common share - basic and diluted $ (1.86) $ (3.01)
Loss from discontinued operations per common share - basic and diluted 0.00 (0.26)
Net loss per common share attributable to common stockholders - basic and diluted $ (0.73) $ (1.94)
Weighted average common shares outstanding - basic and diluted 54,711,838 43,461,978